Bupivacaine

Generic Name
Bupivacaine
Brand Names
Exparel, Kenalog, Marbeta, Marcaine, Marcaine With Epinephrine, Marvona Suik, P-Care M, P-Care MG, P-care, Posimir, Readysharp Anesthetics Plus Ketorolac, Readysharp-A, Readysharp-p40, Readysharp-p80, Sensorcaine, Sensorcaine With Epinephrine, Vivacaine, Xaracoll, Exparel liposomal
Drug Type
Small Molecule
Chemical Formula
C18H28N2O
CAS Number
38396-39-3
Unique Ingredient Identifier
Y8335394RO
Background

Bupivacaine is a widely used local anesthetic agent.

Indication

As an implant, bupivacaine is indicated in adults for placement into the surgical site to produce postsurgical analgesia for up to 24 hours following open inguinal hernia repair.
...

Associated Conditions
Acute Gouty Arthritis, Adrenocortical Insufficiency, Alopecia Areata (AA), Ankylosing Spondylitis (AS), Berylliosis, Bullous dermatitis herpetiformis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Dermatomyositis (DM), Discoid Lupus Erythematosus (DLE), Edema of the cerebrum, Epicondylitis, Hemolytic Anemia, Hypercalcemia caused by Cancer, Keloids Scars, Leukemias, Mycosis Fungoides (MF), Necrobiosis lipoidica diabeticorum, Ocular Inflammation, Ophthalmia, Sympathetic, Osteoarthritis (OA), Pain, Labor, Polymyositis, Postoperative pain, Psoriatic Arthritis, Psoriatic plaque, Pure Red Cell Aplasia, Regional Enteritis, Rheumatoid Arthritis, Secondary thrombocytopenia, Stevens-Johnson Syndrome, Synovitis, Systemic Lupus Erythematosus, Temporal Arteritis, Trichinosis, Tuberculous Meningitis, Ulcerative Colitis, Uveitis, Acute Bursitis, Acute Idiopathic Nephrotic Syndrome, Acute Lupus Erythematosus, Acute Multiple sclerosis, Acute Rheumatic heart disease, unspecified, Acute nonspecific tenosynovitis, Cystic tumors of aponeurosis, Cystic tumors of tendon, Disseminated Pulmonary Tuberculosis (TB), Exfoliative erythroderma, Inflammatory lesions of granuloma annulare, Inflammatory lesions of lichen planus, Inflammatory lesions of lichen simplex, Non-suppurative Thyroiditis, Permphigus, Severe Allergic Reactions
Associated Therapies
General Anesthesia, Local Anaesthesia therapy, Regional nerve block therapy
Clinical Trials
Related News

Analgesia After Total Knee Replacement Surgery

First Posted Date
2011-12-09
Last Posted Date
2015-06-08
Lead Sponsor
St. Antonius Hospital
Target Recruit Count
81
Registration Number
NCT01489631
Locations
🇳🇱

St. Antonius Hospital, Nieuwegein, Netherlands

Safety and Efficacy of Bilateral Superficial Cervical Plexus Block in Thyroidectomy

First Posted Date
2011-10-19
Last Posted Date
2011-10-19
Lead Sponsor
Jawaharlal Institute of Postgraduate Medical Education & Research
Target Recruit Count
60
Registration Number
NCT01454609
Locations
🇮🇳

Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India

Comparison of Quality of Supraclavicular, Infraclavicular and Axillary Approach of Ultrasound-guided Brachial Plexus Block

Not Applicable
Completed
Conditions
Pain
Interventions
Drug: Bupivacaine
First Posted Date
2011-09-28
Last Posted Date
2015-01-21
Lead Sponsor
Hillel Yaffe Medical Center
Target Recruit Count
101
Registration Number
NCT01442558
Locations
🇮🇱

Hillel Yaffe Medical Center, Hadera, Israel

Ultrasound Guided Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic Resection

First Posted Date
2011-08-25
Last Posted Date
2012-08-06
Lead Sponsor
National Cancer Center, Korea
Target Recruit Count
56
Registration Number
NCT01423292
Locations
🇰🇷

National Cancer Center, Goyang, Gyeonggi-do, Korea, Republic of

Caudal Versus Rectus Sheath Study

Phase 2
Terminated
Conditions
Umbilical Hernia
Interventions
Drug: Bupivacaine
First Posted Date
2011-07-14
Last Posted Date
2017-12-19
Lead Sponsor
Nationwide Children's Hospital
Target Recruit Count
39
Registration Number
NCT01394523
Locations
🇺🇸

Nationwide Children's Hospital, Columbus, Ohio, United States

Psoas Compartment Block Versus Fascia Iliaca Block After Total Hip Arthroplasty

Not Applicable
Conditions
Pain
Interventions
Drug: Bupivacaine
Drug: Morphine
First Posted Date
2011-06-23
Last Posted Date
2011-06-23
Lead Sponsor
Hillel Yaffe Medical Center
Target Recruit Count
90
Registration Number
NCT01378949
Locations
🇮🇱

Hillel Yaffe Medical Center, Hadera, Israel

Continuous Subacromial Bupivacaine

Not Applicable
Completed
Conditions
Shoulder Arthroscopy
Interventions
Drug: bupivacaine
First Posted Date
2011-06-21
Last Posted Date
2011-06-22
Lead Sponsor
Turku University Hospital
Target Recruit Count
90
Registration Number
NCT01377415
Locations
🇫🇮

Turku University Hospital and University of Turku, Turku, Finland

Ultrasound-guided Ilioinguinal-iliohypogastric Block for Inguinal Hernia Repair

Phase 4
Conditions
Inguinal Hernia
Interventions
Drug: bupivacaine
Drug: saline
First Posted Date
2011-03-30
Last Posted Date
2011-03-30
Lead Sponsor
Bispebjerg Hospital
Target Recruit Count
60
Registration Number
NCT01326039
Locations
🇩🇰

Copenhagen University Hospital Bispebjerg, Copenhagen, NV, Denmark

Use of Continuous Wound Infusion of Bupivacaine for Analgesia Following Axillary Clearance Surgery

Phase 3
Conditions
Breast Cancer
Interventions
Drug: Bupivacaine
First Posted Date
2011-03-14
Last Posted Date
2011-03-14
Lead Sponsor
Cork University Hospital
Target Recruit Count
42
Registration Number
NCT01314144
Locations
🇮🇪

Cork Universtiy Hospital, Cork, Ireland

Pain Relieving Efficacy of TAP Block in Patients After Laparoscopic Gastric Bypass.

Phase 4
Completed
Conditions
Surgery
Neuromuscular Inhibition
Pain
Obesity
Interventions
Drug: Marcaine
First Posted Date
2011-03-04
Last Posted Date
2014-03-26
Lead Sponsor
Funch-Jensen, Peter, M.D., D.M.Sc.
Target Recruit Count
80
Registration Number
NCT01308554
Locations
🇩🇰

Privathospitalet Hamlet Aarhus, Aarhus N, Denmark

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy